Redhill Biopharma Ltd ADR buy Marianka
Start price
13.08.22
/
50%
€1.06
Target price
13.08.23
€7.20
Performance (%)
-13.55%
End price
23.08.22
€0.91
Summary
This prediction ended on 23.08.22 with a price of €0.91. The price of Redhill Biopharma Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.55%. Marianka has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Redhill Biopharma Ltd ADR | - | - | - |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Marianka what are the pros and cons of Redhill Biopharma Ltd ADR for the foreseeable future?
Pros
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Sustainability is important
Stable Large shareholder and/or long term investor
Top 10 in its market
Known brand
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Differentiated customer and product portfolio
Cons
Very low/no dividend yield expected
very negative Cash Flow expected
Junk rating
High risks in the balance sheet
Little innovation
Growths slower than the competition
Significant cyclical dependencies
Business model of the past or high risk
Few uniques
High valuation
Higher risks for its business